Prosecution Insights
Last updated: May 29, 2026

Examiner: BARHAM, BETHANY P

Tech Center 1600 • Art Units: 1600 1611 1615

This examiner grants 52% of resolved cases

Performance Statistics

51.6%
Allow Rate
-8.4% vs TC avg
524
Total Applications
+32.2%
Interview Lift
1406
Avg Prosecution Days
Based on 510 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
8.0%
§102 Novelty
79.5%
§103 Obviousness
4.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18194849 PROCESSING WATER FROM HYDROCARBON OPERATIONS Final Rejection SAUDI ARABIAN OIL COMPANY
17418091 PHARMACEUTICAL PREPARATION Final Rejection KOWA COMPANY, LTD.
18492882 ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF Non-Final OA Arbor Pharmaceuticals, LLC
18098014 Optimized Topical Formulation for Lidocaine Pain Relief Gel Non-Final OA Focus Consumer Healthcare, LLC
17789698 Methotrexate Dosage Form Non-Final OA ROS Therapeutics ApS
17445992 MODIFIED RELEASE FORMULATIONS OF LEVODOPA Final Rejection RUBICON RESEARCH PRIVATE LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month